With this approach, we successfully transdifferentiated BRAF-mutated (A375, HT144, MA1) and NRAS-mutated human melanoma cells (SKMel30, SKMel103) as well as murine Ret melanoma cells derived from Ret transgenic mice [19] (Fig. S2). The gene discussed is NRAS; the disease is melanoma.